{"filing":{"accession_number":"0001213900-26-086146","cik":"0001975641","ticker":"ZYBT","company_name":"Zhengye Biotechnology Holding Ltd","form":"6-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"ea0300942-6k_zhengye.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1975641/000121390026086146/ea0300942-6k_zhengye.htm"},"events":[{"id":24563,"run_id":22275,"accession_number":"0001213900-26-086146","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"The press release announces that Zhengye has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after previously falling below that threshold for 30 consecutive business days (notification received May 29, 2026). While the announcement is positive (regaining compliance), it discloses a material delisting risk event—the Company was in non-compliance with a continued listing standard and faced potential delisting. The disclosure of the prior non-compliance and the path to remediation is material to investors assessing listing status and regulatory standing.","company_name":"Zhengye Biotechnology Holding Ltd","ticker":"ZYBT","filing_date":"2026-08-06","form":"6-K","submitted_at":null,"items":[{"id":25163,"accession_number":"0001213900-26-086146","item_number":"EX-99.1","item_title":"ea030094201ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The press release announces that Zhengye has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after previously falling below that threshold for 30 consecutive business days (notification received May 29, 2026). While the announcement is positive (regaining compliance), it discloses a material delisting risk event—the Company was in non-compliance with a continued listing standard and faced potential delisting. The disclosure of the prior non-compliance and the path to remediation is material to investors assessing listing status and regulatory standing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:12:04.281151+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25163,"accession_number":"0001213900-26-086146","item_number":"EX-99.1","item_title":"ea030094201ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The press release announces that Zhengye has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after previously falling below that threshold for 30 consecutive business days (notification received May 29, 2026). While the announcement is positive (regaining compliance), it discloses a material delisting risk event—the Company was in non-compliance with a continued listing standard and faced potential delisting. The disclosure of the prior non-compliance and the path to remediation is material to investors assessing listing status and regulatory standing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:12:04.281151+00:00","company_name":"Zhengye Biotechnology Holding Ltd","ticker":"ZYBT","filing_date":"2026-08-06"}]}